ArticleBMC anesthesiology2025
Risk factors for morphine-associated sedation in intravenous patient-controlled analgesia for postoperative pain.
Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundOpioid-related oversedation is associated with respiratory depression and can lead to potentially catastrophic adverse events in hospitalized patients. This study aimed to investigate influential factors for postoperative sedation during morphine-based intravenous patient-controlled analgesia (IV-PCA).
methodsWe enrolled patients who received morphine-based IV-PCA for postoperative pain at a medical hospital between January 2020 and November 2022. The primary outcome was unintentional sedation within 72 h after surgery. The Observer Assessment of Alertness/Sedation Scale (OAA/S) was used to assess the sedation depth at 12-hour intervals. Multivariable logistic regression models were used to calculate the adjusted odds ratio (aOR) with 95% confidence interval (CI) for the outcome of interest.
resultsA total of 1,461 patients were included for analyses. The multivariable analysis identified six independent factors for morphine-associated sedation, including age (aOR: 1.019, 95% CI: 1.008-1.030), current alcohol drinking (aOR: 2.14, 95% CI: 1.24-3.68), preoperative hemoglobin level (aOR: 0.41, 95% CI: 0.21-0.81, on base-2 logarithmic scale), intraoperative use of midazolam (aOR: 1.62, 95% CI: 1.07-2.45), basal morphine infusion (aOR: 2.08, 95% CI: 1.16-3.71), and duration of IV-PCA (aOR: 1.97, 95% CI: 1.09-3.57, on base-2 logarithmic scale). Basal morphine infusion was also associated with moderate-to-deep sedation (OAA/S score ≤ 3) (aOR: 2.75, 95% CI: 1.38-5.46). Furthermore, the combination of intraoperative midazolam use and basal morphine infusion was associated with an increased risk of sedation, suggesting a potential synergistic relationship.
conclusionThe identified risk factors for morphine-associated oversedation can facilitate early identification and prevention of complications in high-risk populations. Our findings suggest that perioperative use of sedative-hypnotics and continuous opioid infusions should be approached cautiously in at-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.